- Trials with a EudraCT protocol (231)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
231 result(s) found for: Immunoglobulin E.
Displaying page 1 of 12.
EudraCT Number: 2016-003438-26 | Sponsor Protocol Number: 161504 | Start Date*: 2017-02-14 | |||||||||||
Sponsor Name:Baxalta US Inc. | |||||||||||||
Full Title: Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric Subjects with Primary Immunodeficiency Diseases | |||||||||||||
Medical condition: Primary Immunodeficiency Disease (PIDD) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) SE (Completed) DK (Completed) CZ (Completed) SK (Completed) FR (Completed) GR (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001982-42 | Sponsor Protocol Number: J004 | Start Date*: 2012-08-02 | |||||||||||
Sponsor Name:Guy's & St. Thomas' NHS Foundation Trust | |||||||||||||
Full Title: Investigation of a novel intervention in Acute HIV infection (AHI) on long term latent HIV reservoir size: A pilot study of antiretroviral therapy plus immunoglobulin in AHI | |||||||||||||
Medical condition: Acute HIV Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003652-52 | Sponsor Protocol Number: 991 | Start Date*: 2016-09-29 | |||||||||||
Sponsor Name:Biotest AG | |||||||||||||
Full Title: An open label, prospective, multicenter study investigating clinical efficacy, safety, and pharmacokinetic properties of the human normal immunoglobulin for intravenous administration BT595 as repl... | |||||||||||||
Medical condition: Replacement therapy in patients with primary immunodeficiency disease (PID) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000481-38 | Sponsor Protocol Number: 161102 | Start Date*: 2012-06-28 | |||||||||||
Sponsor Name:Baxter Innovations GmbH | |||||||||||||
Full Title: Tolerability, Safety and Product Administration Evaluation of rHuPH20 Facilitated Subcutaneous Treatment with Immune Globulin (Human), 10% in Subjects with Primary Immunodeficiency Diseases – A Stu... | |||||||||||||
Medical condition: Primary Immunodeficiency Diseases | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-005362-18 | Sponsor Protocol Number: HBIGforcure | Start Date*: 2022-04-13 | |||||||||||
Sponsor Name:Hannover Medical School | |||||||||||||
Full Title: Hepatitis B immunoglobulins to induce HBsAg clearance in patients with chronic hepatitis B | |||||||||||||
Medical condition: HBeAg negative patients with chronic HBV infection will be allocated into two different cohorts, cohort A and cohort B. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-005496-87 | Sponsor Protocol Number: 161403 | Start Date*: 2015-10-15 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human... | |||||||||||||
Medical condition: Chronic inflammatory demyelinating polyradiculoneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) DK (Completed) DE (Completed) SE (Completed) GB (GB - no longer in EU/EEA) ES (Completed) NO (Completed) SK (Completed) GR (Completed) AT (Completed) PL (Completed) HR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002997-35 | Sponsor Protocol Number: OVG2014/05 | Start Date*: 2015-02-06 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: A phase III multi-centre randomised, double blind, placebo controlled trial to assess the role of intravenous immunoglobulin in the management of children with encephalitis (The IgNiTE study) | |||||||||||||
Medical condition: Encephalitis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019459-23 | Sponsor Protocol Number: 170903 | Start Date*: 2011-01-18 | |||||||||||
Sponsor Name:Baxter Innovations GmbH | |||||||||||||
Full Title: A CLINICAL STUDY OF IMMUNE GLOBULIN SUBCUTANEOUS (HUMAN) (IGSC), 20% FOR THE EVALUATION OF EFFICACY, SAFETY, AND PHARMACOKINETICS IN SUBJECTS WITH PRIMARY IMMUNODEFICIENCY DISEASES | |||||||||||||
Medical condition: Primary Immunodeficiency Diseases | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) AT (Completed) GB (Completed) HU (Completed) SE (Completed) NL (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003653-17 | Sponsor Protocol Number: 992 | Start Date*: 2017-01-27 | |||||||||||
Sponsor Name:Biotest AG | |||||||||||||
Full Title: An open label, prospective, randomized, multicenter study investigating clinical efficacy and safety of the human normal immunoglobulin for intravenous administration BT595 in patients with chronic... | |||||||||||||
Medical condition: Chronic primary immune thrombocytopenia (ITP) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) ES (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-002533-42 | Sponsor Protocol Number: ARC002 | Start Date*: 2021-12-07 |
Sponsor Name:Aimmune Therapeutics, Inc. | ||
Full Title: Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen (CPNA) Peanut Oral Immunotherapy (OIT) Safety Follow-On Study | ||
Medical condition: Peanut Allergy | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2012-001327-12 | Sponsor Protocol Number: FIBHGM-ECNC001-2012 | Start Date*: 2012-11-19 | |||||||||||
Sponsor Name:Fundacion para la Investigación Biomédica del Hospital Gregorio Marañón | |||||||||||||
Full Title: Assessing the efficacy and toxicity of intravenous immunoglobulin for the treatment of infections in patients with post solid organ transplantation IgG hypogammaglobulinemia | |||||||||||||
Medical condition: infections in patients with post solid organ transplantation IgG hypogammaglobulinemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004766-26 | Sponsor Protocol Number: NL58747 | Start Date*: 2017-03-08 |
Sponsor Name:Academic Medical Center | ||
Full Title: Intravenous immunoglobulins as early treatment in newly diagnosed idiopathic inflammatory myopathies (IMMEDIATE): a pilot study. | ||
Medical condition: idiopathic inflammatory myopathies | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004523-21 | Sponsor Protocol Number: V1605-201 | Start Date*: 2020-09-03 | |||||||||||
Sponsor Name:DBV Technologies S.A. | |||||||||||||
Full Title: A Phase 2 Study to Evaluate the Sensitivity and Specificity of DBV1605, a Ready to Use Atopy Patch Test for the Diagnosis of Non-Immunoglobulin E Mediated Cow’s Milk Allergy in Children. | |||||||||||||
Medical condition: Non-Immunoglobulin E Mediated Cow’s Milk Allergy | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004346-42 | Sponsor Protocol Number: 3150-301-008 | Start Date*: 2019-09-10 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A 52-Week, Multicenter, Randomized, Double-blind, Double-dummy, Placebo and Active-controlled, Operationally Seamless Phase 2b/3, Parallel-group Study to Assess the Efficacy and Safety of Brazikuma... | |||||||||||||
Medical condition: Crohn's Disease | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) ES (Prematurely Ended) BG (Prematurely Ended) AT (Prematurely Ended) CZ (Prematurely Ended) HU (Prematurely Ended) BE (Not Authorised) IT (Prematurely Ended) SK (Prematurely Ended) RO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000479-28 | Sponsor Protocol Number: LTS13932 | Start Date*: 2015-08-17 | |||||||||||
Sponsor Name:Genzyme Corporation | |||||||||||||
Full Title: A Phase II Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous Leukemia | |||||||||||||
Medical condition: Acute Myeloid Leukemia NOS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001605-93 | Sponsor Protocol Number: 3151-201-008 | Start Date*: 2019-07-01 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A 54-Week Treatment, Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo and Active-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy and Safety of Brazikumab in Participants... | |||||||||||||
Medical condition: Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DE (Completed) BE (Completed) CZ (Prematurely Ended) ES (Prematurely Ended) BG (Prematurely Ended) AT (Prematurely Ended) HU (Prematurely Ended) IT (Prematurely Ended) RO (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007027-11 | Sponsor Protocol Number: EPAIM-01 | Start Date*: 2009-03-18 |
Sponsor Name:AZIENDA OSPEDALIERA CARDARELLI | ||
Full Title: OTTIMIZZAZIONE DELLA PROFILASSI CON IMMUNOGLOBULINE ANTIEPATITE B (HBIG) IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO PER EPATOPATIA CORRELATA AL VIRUS DELL`EPATITE B (HBV) | ||
Medical condition: PROFILASSI PER RECIDIVA INFEZIONE HBV IN PAZIENTI TRAPIANTATI EPATICI | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000645-14 | Sponsor Protocol Number: EFC16035 | Start Date*: 2020-10-13 | |||||||||||
Sponsor Name:Genzyme Corporation | |||||||||||||
Full Title: A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS) | |||||||||||||
Medical condition: Primary Progressive Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) BG (Ongoing) EE (Ongoing) GB (GB - no longer in EU/EEA) DK (Ongoing) NO (Temporarily Halted) CZ (Ongoing) GR (Ongoing) LV (Ongoing) DE (Restarted) BE (Ongoing) HU (Ongoing) NL (Restarted) PT (Ongoing) IT (Ongoing) HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003298-24 | Sponsor Protocol Number: EVITAESTEROIDE-12 | Start Date*: 2014-06-26 | |||||||||||
Sponsor Name:Sociedad Andaluza de Trasplante de Órganos y Tejidos (SATOT) | |||||||||||||
Full Title: Steroid withdrawal and novo donor-specific anti-HLA antibodies in renal transplant patients: a prospective, randomized and controlled study in parallel groups. | |||||||||||||
Medical condition: Kidney transplantaion | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000906-31 | Sponsor Protocol Number: IgPro10_2001 | Start Date*: 2020-05-22 | ||||||||||||||||
Sponsor Name:CSL Behring GmbH | ||||||||||||||||||
Full Title: A Randomized, Multicenter, Double-Blind, Placebo Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of IgPro10 (Intravenous Immunoglobulin, Privigen®) for the Treatment of Adults with Sy... | ||||||||||||||||||
Medical condition: efficacy and safety in subjects with diffuse cutaneous systemic sclerosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) FR (Completed) PL (Prematurely Ended) BE (Completed) ES (Prematurely Ended) IT (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.